Menu

Life Sciences

Insightful, customized solutions for innovative business leaders

In today’s fast-paced marketplace and complicated regulatory environment, operating in the life sciences industry can bring a variety of challenges. From raising and managing capital to protecting intellectual property and prioritizing research and development efforts, you require business advisors who understand your complex issues and the specific business problems you might face.

Recommended Insight

INSIGHT ARTICLE

Finance & Accounting for Bioscience Companies conference: Key insights

Conference speakers shared insights on how to effectively scale bioscience businesses as well as best practices on accounting and reporting.

VIDEO

A tale of two labor markets

Labor challenges are in play for both U.S. businesses and policymakers. Listen and learn about workforce dynamics for the future economy.

ARTICLE

Bribery and corruption in the life sciences sector

This recent interview with Risk & Compliance magazine discusses the unique bribery and corruption risks life sciences organizations face.

EU value added tax refund potential for pharmaceutical companies

TAX BLOG

EU value added tax refund potential for pharmaceutical companies

A recent opinion by the Advocate General (AG) for the European Court of Justice (ECJ) opens the door for pharmaceutical companies to potentially claw back previously charged value added tax (VAT).

WHITE PAPER

Changes to revenue recognition in the life sciences industry

A white paper about how entities in the life sciences industry may be affected by the new revenue recognition guidance in ASC 606.

What life sciences boards need to understand about corruption risk

INSIGHT ARTICLE

What life sciences boards need to understand about corruption risk

Learn what the board and others who have executive oversight of life sciences companies need to understand about minimizing corruption risk.

INSIGHT ARTICLE

Understanding R&D credit benefits for the life sciences industry

Resources to help you gain an understanding of the eligibility criteria and re-examine your eligibility for the R&D credit.

INSIGHT ARTICLE

Mass. court holds biotech firm engaged in substantial manufacturing

California biotech firm sees larger corporate tax bill after Massachusetts high court determination that it was engaged in manufacturing.

INSIGHT ARTICLE

Improvements to employee share-based payment accounting

Learn about improvements to the share-based compensation standard and its impact on the life sciences industry.

INSIGHT ARTICLE

The benefits of finance and accounting outsourcing for life sciences

Learn how growing life sciences companies leverage finance and accounting outsourcing to enhance the finance function and focus on core competencies.

Life Sciences Insights

( * = Required fields)

Contact Our Team

John Lanza  LinkedIn
National Life Sciences Practice Leader

800.274.3978
John.Lanza@rsmus.com



EVENTS / WEBCASTS

LIVE WEBCAST

The next generation cloud: Are you in cloud infancy or maturity?

Cloud technologies continue to evolve and offer more complex solutions. Learn the benefits, philosophies and considerations behind each.

  • October 26, 2017